Merrimack Pharmaceuticals IPO watch: Merrimack Pharmaceuticals announced its public offering price at $7 per share and it will offer 14.30 million in this deal in order to raise funds of $100 million.
The company plans to trade on NASDAQ under the ticker symbol “MACK” on Thursday. JP Morgan is acting as the representatives of the Merrimack Pharmaceuticals IPO’s underwriters.
According to the previously filed documents, the company had planned to offer 16.67 million shares of common stock at the offering price range of $8 to $10, but the company postponed the public offering in mid-January this year.
Merrimack Pharmaceuticals is engaged in research and treatment on cancer through the network of biological systems.
Merrimack Pharmaceuticals IPO